Alternative Names
CDX-1127 research-grade biosimilar ;CD27 antibody; TNFRSF7 antibody; CD27 antigen antibody; CD27L receptor antibody; T-cell activation antigen CD27 antibody; T14 antibody; Tumor necrosis factor receptor superfamily member 7 antibody; CD antigen CD27 antibody
Immunogen
Recombinant Human CD27 protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.780
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.